Corcept (CORT) insider files Form 144 to sell 2,200 shares

Rhea-AI Filing Summary

Corcept Therapeutics (CORT) filed a Form 144 reporting an intended sale of 2,200 common shares through Fidelity on NASDAQ with an aggregate market value of $159,060. The filing lists total shares outstanding of 105,371,729, showing the proposed block represents a very small fraction of outstanding stock.

The securities are shown as acquired in connection with an option granted 08/20/2018 and the filing indicates acquisition and proposed sale activity on 08/11/2025 for cash. The filer, Daniel Swisher, also reported three prior sales in the past three months (2,200 shares each on 05/12/2025, 06/10/2025 and 07/10/2025) with listed gross proceeds for each sale.

Insights

Financial Analyst

TL;DR: Routine insider sale; size is immaterial relative to shares outstanding.

The Form 144 documents an intended sale of 2,200 common shares valued at $159,060. With 105,371,729 shares outstanding, the block is a minuscule portion of the float. The filing cites acquisition via an option granted 08/20/2018 and a cash sale routed through Fidelity on NASDAQ. Recent, small prior dispositions are disclosed for May, June and July 2025. Overall, the filing appears procedural rather than market-moving.

Corporate Governance Expert

TL;DR: Multiple recent insider sales disclosed; disclosure meets Form 144 requirements and shows no obvious material governance concern.

The notice identifies the seller (Daniel Swisher) and details consecutive small sales of 2,200 shares across three months, plus a current proposed 2,200-share sale. The securities are tied to an option grant dated 08/20/2018 and the transaction is to be executed for cash via Fidelity on NASDAQ. From a compliance and disclosure standpoint, the filing provides the standard facts required by Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2200	159060.00	105371729	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/11/2025	Option Granted - 08/20/2018	Issuer			2200	08/11/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Daniel Swisher 101 Redwood Shores Parkway Redwood City CA 94065	Common	05/12/2025	2200	158526.00
Daniel Swisher 101 Redwood Shores Parkway Redwood City CA 94065	Common	06/10/2025	2200	155342.00
Daniel Swisher 101 Redwood Shores Parkway Redwood City CA 94065	Common	07/10/2025	2200	156376.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)